← Back to Conditions

Pityriasis rubra pilaris

disorder
SNOMED 3755001CUI C0032027

Overview

Pityriasis rubra pilaris is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Research Evidence

Peer-reviewed studies linked via MeSH term "Pityriasis Rubra Pilaris" from the MEDLINE/PubMed database.

Sort:
Role of IL-23 inhibitors including risankizumab and guselkumab in the treatment of pityriasis rubra pilaris.
[object Object], [object Object], [object Object] · Arch Dermatol Res · 2024
PMID: 38844710Meta-Analysis
Biologics for inherited disorders of keratinisation: A systematic review.
[object Object], [object Object], [object Object] et al. · Australas J Dermatol · 2024
PMID: 38126177Meta-Analysis
Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review.
[object Object], [object Object], [object Object] et al. · J Am Acad Dermatol · 2023
PMID: 37640244Meta-Analysis
Eosinophils in Traditionally Noneosinophil-Rich Dermatoses.
[object Object], [object Object], [object Object] et al. · Am J Dermatopathol · 2023
PMID: 37883982Meta-Analysis
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.
[object Object], [object Object], [object Object] et al. · Arch Dermatol Res · 2022
PMID: 34156549Meta-Analysis
Drugs associated with development of pityriasis rubra pilaris: A systematic review.
[object Object], [object Object], [object Object] et al. · J Am Acad Dermatol · 2021
PMID: 32687965Meta-Analysis
Systemic therapies of pityriasis rubra pilaris: a systematic review.
[object Object], [object Object], [object Object] et al. · J Dtsch Dermatol Ges · 2019
PMID: 30520557Meta-Analysis
Treatment of pityriasis rubra pilaris type I: a systematic review.
[object Object], [object Object], [object Object] · Eur J Dermatol · 2019
PMID: 31789274Meta-Analysis
A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists.
[object Object], [object Object], [object Object] et al. · J Eur Acad Dermatol Venereol · 2013
PMID: 22324561Meta-Analysis
Pityriasis rubra pilaris--a retrospective single center analysis over eight years.
[object Object], [object Object], [object Object] et al. · J Dtsch Dermatol Ges · 2010
PMID: 20202046Meta-Analysis

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Irregular hyperpigmentation
Very frequent (80-99%)HP:0007400
Keratoderma
Very frequent (80-99%)HP:0000982
Papules
Very frequent (80-99%)HP:0200034
Red scaly skin caused by inflammatory skin disease
Very frequent (80-99%)HP:0001019
Abnormal nail morphology
Frequent (30-79%)HP:0001597
Diffusely thickened skin
Frequent (30-79%)HP:0001072
Skin itching
Frequent (30-79%)HP:0000989
Thickened, discoloured skin under nail
Frequent (30-79%)HP:0008392
Abnormal oral cavity morphology
Occasional (5-29%)HP:0000163
Eczema
Occasional (5-29%)HP:0000964
Everted eyelid
Occasional (5-29%)HP:0000656
Ichthyosiform abnormality of the skin
Occasional (5-29%)HP:0008064
Lichenification
Occasional (5-29%)HP:0100725
Oncology
Occasional (5-29%)HP:0002664
Pimple
Occasional (5-29%)HP:0200039
Erythematous plaque
HP:0025474
Hypergranulosis
HP:0025114
Keratosis pilaris
HP:0032152
Orthokeratosis
HP:0040162
Parakeratosis
HP:0001036

Quick Facts

SNOMED CT
3755001
UMLS CUI
C0032027
Fully Specified Name
Pityriasis rubra pilaris (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
20
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.